CVE:ENTG Entourage Health (ENTG) Stock Price, News & Analysis → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free ENTG Stock Alerts C$0.02 +0.01 (+50.00%) (As of 05:28 PM ET) Add Compare Share Share Today's RangeC$0.01▼C$0.0250-Day RangeC$0.01▼C$0.0252-Week RangeC$0.01▼C$0.03Volume22,172 shsAverage Volume91,424 shsMarket CapitalizationC$4.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get Entourage Health alerts: Email Address Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Entourage Health Stock (CVE:ENTG)Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. It offers cannabis plants, dried flower, pre-rolls, soft chews, chewing gum, cannabis oils, capsules, topicals and vapes, extracts, and edibles. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Syndicate Cannabis, Mary's Medicinals, and Irwin Naturals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.Read More ENTG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENTG Stock News HeadlinesMay 28, 2024 | msn.comEntourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'May 28, 2024 | finance.yahoo.comEntourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive QuarterMay 14, 2024 | markets.businessinsider.comEntourage Health to Hold First Quarter 2024 Financial Results Call on May 28May 2, 2024 | finance.yahoo.comEntourage Health Full Year 2023 Earnings: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022)April 30, 2024 | finanznachrichten.deEntourage Health Corp.: Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total RevenuesMarch 30, 2024 | yahoo.comA Different Type of EntourageJanuary 30, 2024 | theglobeandmail.comClosing Bell: Entourage Health Corp up on Tuesday (ENTG)December 28, 2023 | theglobeandmail.comClosing Bell: Entourage Health Corp up on Thursday (ENTG)December 13, 2023 | theglobeandmail.comClosing Bell: Entourage Health Corp down on Wednesday (ENTG)December 5, 2023 | markets.businessinsider.comEntourage Health Provides Corporate UpdateNovember 29, 2023 | theglobeandmail.comEntourage Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ENTG)November 27, 2023 | theglobeandmail.comEntourage Health: Top 25 Undervalued TSX Venture Exchange Stocks (ENTG)November 26, 2023 | theglobeandmail.comEntourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)November 8, 2023 | finance.yahoo.comEntourage Health to Host Third Quarter 2023 Financial Results Call on November 28October 10, 2023 | theglobeandmail.comClosing Bell: Entourage Health Corp down on Friday (ENTG)August 30, 2023 | finanznachrichten.deEntourage Health Corp.: Entourage Health Reports Second Quarter 2023 Financial ResultsAugust 30, 2023 | finance.yahoo.comEntourage Health Reports Second Quarter 2023 Financial ResultsAugust 30, 2023 | benzinga.comTwo Key Cannabis Trends Surged - Entourage Health's Financial Results Show WhyAugust 24, 2023 | finance.yahoo.comEntourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft CannabisAugust 21, 2023 | theglobeandmail.comClosing Bell: Entourage Health Corp down on Monday (ENTG)August 17, 2023 | theglobeandmail.comClosing Bell: Entourage Health Corp up on Wednesday (ENTG)August 9, 2023 | finance.yahoo.comEntourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30August 1, 2023 | finance.yahoo.comInvestors Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) RevenuesJuly 4, 2023 | finance.yahoo.comEntourage Health Announces International Sale of Bulk Cannabis to AustraliaJune 19, 2023 | stockhouse.comEntourage Health Announces Restructuring of Senior Secured DebtSee More Headlines Receive ENTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entourage Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:ENTG CUSIPN/A CIKN/A Webwww.entegris.com Phone19784366500FaxN/AEmployees5,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-46,170,000.00 Net Margins-113.40% Pretax MarginN/A Return on Equity-371.10% Return on Assets-34.32% Debt Debt-to-Equity Ratio2,914.72 Current Ratio0.15 Quick Ratio0.91 Sales & Book Value Annual SalesC$40.71 million Price / Sales0.11 Cash FlowC$0.01 per share Price / Cash Flow1.35 Book ValueC($0.48) per share Price / Book-0.03Miscellaneous Outstanding Shares308,390,000Free FloatN/AMarket CapC$4.63 million OptionableNot Optionable Beta0.97 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. George Scorsis (Age 46)Executive Chair & CEO Comp: $541.1kMs. Vaani MaharajChief Financial OfficerMr. James AfaraChief Operating OfficerDr. Alexandre SibilevVice-President of Quality Assurance & Global Regulatory ComplianceMs. Marianella DelaBarreraSenior Vice President of Communications & Corporate AffairsMr. Jeff KeyesSenior Vice President of OperationsDr. Peter BlecherChief Medical OfficerMr. Joseph MeleChief Commercial OfficerPat ScanlonHead of CultivationCatherine FlamanSenior Director of Communications & Corporate AffairsMore ExecutivesKey Competitors48North CannabisCVE:NRTHNuvo PharmaceuticalsTSE:MRVMedicureCVE:MPHIndivaCVE:NDVAFlowrCVE:FLWRView All Competitors ENTG Stock Analysis - Frequently Asked Questions How have ENTG shares performed in 2024? Entourage Health's stock was trading at C$0.02 at the beginning of the year. Since then, ENTG stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. How do I buy shares of Entourage Health? Shares of ENTG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ENTG) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersWho are Nvidia’s Silent Partners?Weiss RatingsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceThe Only Energy Play You Should Be Looking AtWealthpin Pro[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyCollapse of the Petrodollar Colonial Metals[Webinar] Understanding Covered CallsOICWhat’s Pelosi Buying Now?Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entourage Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.